Last $530.94 USD
Change Today +4.78 / 0.91%
Volume 74.3K
ISRG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

intuitive surgical inc (ISRG) Snapshot

Open
$528.61
Previous Close
$526.16
Day High
$534.27
Day Low
$523.80
52 Week High
04/3/14 - $541.23
52 Week Low
05/9/14 - $346.46
Market Cap
19.2B
Average Volume 10 Days
206.6K
EPS TTM
$13.10
Shares Outstanding
36.3M
EX-Date
--
P/E TM
40.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTUITIVE SURGICAL INC (ISRG)

intuitive surgical inc (ISRG) Details

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci surgical system translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci surgical system comprise a surgeon’s console, a patient-side cart, a 3-D vision system, da Vinci skills simulator, and Firefly fluorescence imaging product that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general surgery, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments consisting of forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci single-site instruments and accessories that allow da Vinci Si surgical systems to work through a single incision; and EndoWrist One vessel sealer, a wristed single-use instrument intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in anastomoses in general, gynecologic, and urologic surgery; and sells various accessory productsdiameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist Stapler 45 instrument, a wristed stapling instrument intended for resection, transaction, and/or creation of, such as sterile drapes, 3-D stereo endoscopes, camera heads, light guides, and other items that are used in conjunction with the da Vinci surgical system. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.

2,792 Employees
Last Reported Date: 02/3/14
Founded in 1995

intuitive surgical inc (ISRG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $560.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $391.4K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $380.0K
Chief Compliance Officer, Senior Vice Preside...
Total Annual Compensation: $365.7K
Principal Accounting Officer and Vice Preside...
Total Annual Compensation: $227.6K
Compensation as of Fiscal Year 2013.

intuitive surgical inc (ISRG) Key Developments

Intuitive Surgical, Inc.(NasdaqGS:ISRG) dropped from S&P 500 Value Index

Intuitive Surgical, Inc.(NasdaqGS:ISRG) dropped from S&P 500 Value Index

Intuitive Surgical, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 09:45 AM

Intuitive Surgical, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 09:45 AM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Intuitive Surgical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Intuitive Surgical, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company’s revenue was $550 million, an increase of approximately 10% compared with $499 million in the third quarter of 2013. Non-GAAP revenue was $534 million, an increase of approximately 7% compared with $499 million in the third quarter of 2013. Income from operations decreased to $159 million, compared with $174 million in the third quarter of 2013. Non-GAAP income from operations decreased to $197 million, compared with $230 million in the third quarter of 2013. Net income was $124 million, or $3.35 per diluted share, compared with $157 million, or $3.99 per diluted share, for the third quarter of 2013. Non-GAAP net income was $145 million, or $3.92 per diluted share, compared with $194 million, or $4.94 per diluted share, for the third quarter of 2013. Income before taxes was $161.1 million against $178.1 million a year ago. For the nine months, the company reported total revenue of $1,527.0 million against $1,688.9 million a year ago. Income from operations was $358.7 million against $643.9 million a year ago. Income before taxes was $364.2 million against $656.4 million a year ago. Net income was $272.0 million or $7.18 per diluted share against $504.8 million or $12.46 per diluted share a year ago. Non-GAAP revenue was $1,530.9 million against $1,688.9 million a year ago. Non-GAAP income from operations was $581.7 million against $787.8 million a year ago. Non-GAAP net income was $423.4 million or $11.17 per diluted share against $601.6 million or $14.85 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISRG:US $530.94 USD +4.78

ISRG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $65.10 USD -0.21
CR Bard Inc $169.10 USD -0.44
Edwards Lifesciences Corp $130.75 USD +1.17
Endo International PLC $72.10 USD +0.34
Zimmer Holdings Inc $114.11 USD +0.64
View Industry Companies
 

Industry Analysis

ISRG

Industry Average

Valuation ISRG Industry Range
Price/Earnings 46.2x
Price/Sales 9.1x
Price/Book 6.2x
Price/Cash Flow 43.9x
TEV/Sales 8.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTUITIVE SURGICAL INC, please visit www.intuitivesurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.